|
|
|
|
|
|
|
Soleno Therapeutics Inc (SLNO)
|
|
1.85 0.05 (2.78%)
|
04-20 15:59
|
|
Open:
|
1.8342
|
Pre. Close:
|
1.8
|
|
High:
|
1.88
|
Low:
|
1.8
|
|
Volume:
|
16,750
|
Market Cap:
|
36M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
1.882 - 1.891
|
1.891 - 1.899
|
|
Low:
|
1.779 - 1.789
|
1.789 - 1.798
|
|
Close:
|
1.834 - 1.851
|
1.851 - 1.865
|
|
|
|
Technical analysis (as of: 2018-04-20 4:33:38 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 2.36 One year: 2.76
|
|
Support:
|
Support1: 1.73 Support2: 1.55
|
|
Resistance:
|
Resistance1:
2.02 Resistance2: 2.36
|
|
Pivot:
|
1.81
|
|
Moving Averages:
|
MA(5): 1.82 MA(20): 1.83 
MA(100): 1.77 MA(250): 2.29
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9):
|
|
%K %D:
|
%K(14,3): 60.74 %D(3): 59.01
|
|
RSI:
|
RSI(14): 53.65
|
|
52-Week:
|
High: 3.75
Low: 1.317 Change(%): -33.9
|
|
Average Vol(K):
|
3-Month: 3289
10-Days 3243
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SLNO has closed below upper band by 4.5%. Bollinger Bands are 75.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to SLNO's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-02-21T11:49:59-05:00
Your Daily Pharma Scoop: Portola Update, Wave Life Sciences To Collaborate With Takeda, AbbVie Reports Data For Egolix
2017-12-21T00:18:09-05:00
Daily Insider Ratings Round Up 12/19/17: BAS, GBT, PSEC, DRNA, SLNO
2017-12-12T12:50:18-05:00
Soleno Therapeutics secures private $15M capital raise; shares up 2%
2017-12-11T07:00:00-05:00
Your Daily Pharma Scoop: Celgene Upside, Erytech Tumbles, Novartis Neulasta Biosimilar
2017-12-08T08:42:47-05:00
Soleno up 16% premarket on move away from Capnia
2017-10-12T09:55:41-04:00
EMA advisory group backs Orphan Drug tag for Soleno's DCCR for Prader-Willi syndrome; shares up 2%
2017-05-11T16:35:20-04:00
Capnia misses by $0.04, beats on revenue
2017-03-15T16:36:57-04:00
Capnia beats by $0.07, misses on revenue
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
